All Insights
Showing 37 - 48 of 245
Brexit
How will the Retained EU Law Bill affect UK and international businesses?
A slow passage in Parliament has added to uncertainty as businesses and their risk managers look to prepare for change
Intellectual property
UK sets out the new Science and Technology Framework
Government growth ambitions for critical technologies including AI and future telecoms require regulatory clarity
Employment and pensions
What effect will the Spring Budget 2023 have on UK immigration?
Policy to simplify business visitor rules may enable visitors to conduct a wider range of business activities in the UK
Life Sciences and Healthcare
Spring Budget 2023 | UK chancellor announces new regulatory model for medicines and medical technologies
Move raises the question of whether regulatory framework for medicines and medical devices will diverge from the EU model in
Dispute resolution
Choice of courts: Are asymmetric jurisdiction clauses still a good idea post-Brexit?
Asymmetric jurisdiction clauses bring with them new risks in an EU context, to be weighed on a deal-by-deal basis –
Regulatory Outlook
Health and safety | UK Regulatory Outlook February 2023
Developers given six weeks to sign contract to fix unsafe buildings | Risks posed by falling trees | Building Safety
Regulatory Outlook
Products | UK Regulatory Outlook February 2023
Medical Technology Strategy | UK to introduce regulatory framework for point of care manufacturing | Commission launches call for evidence
Brexit
The UK Retained EU Law Bill: legislative havoc or promised post-Brexit deregulation?
As the House of Lords begins its second reading of the controversial bill, we look at what it does, what
Regulatory Outlook
Food law | UK Regulatory Outlook January 2023
New novel foods? | Genetically modified crops? | New timescales for HFSS products
Knowledge Notes
UK business law predictions for 2023
As the new year unfolds, we look ahead at what legal developments businesses can expect
The Built Environment
A look ahead for UK real estate in 2023
The new year will be a busy one – including the implementation of new regimes for overseas ownership of UK
Life Sciences and Healthcare
Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device
'Urgent need to get the regulation right' says RHC report which recommends an increase in regulatory capacity and capability to
